Next Financial Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $257K | Buy |
554
+81
| +17% | +$37.6K | 0.02% | 799 |
|
|
2021
Q3 | $176K | Buy |
473
+34
| +8% | +$12.7K | 0.01% | 893 |
|
|
2021
Q2 | $168K | Sell |
439
-146
| -25% | -$55.9K | 0.01% | 892 |
|
|
2021
Q1 | $210K | Buy |
585
+151
| +35% | +$54.2K | 0.02% | 758 |
|
|
2020
Q4 | $139K | Buy |
434
+19
| +5% | +$6.09K | 0.01% | 851 |
|
|
2020
Q3 | $112K | Buy |
+415
| New | +$112K | 0.01% | 816 |
|
|
2020
Q2 | – | Sell |
-421
| Closed | -$96K | – | 944 |
|
|
2020
Q1 | $96K | Sell |
421
-61
| -13% | -$13.9K | 0.01% | 768 |
|
|
2019
Q4 | $146K | Sell |
482
-767
| -61% | -$232K | 0.02% | 805 |
|
|
2019
Q3 | $299K | Sell |
1,249
-26
| -2% | -$6.22K | 0.03% | 500 |
|
|
2019
Q2 | $360K | Buy |
1,275
+368
| +41% | +$104K | 0.04% | 445 |
|
|
2019
Q1 | $260K | Buy |
907
+533
| +143% | +$153K | 0.07% | 297 |
|
|
2018
Q4 | $98K | Buy |
374
+293
| +362% | +$76.8K | 0.02% | 592 |
|
|
2018
Q3 | $22K | Buy |
+81
| New | +$22K | 0.01% | 749 |
|
|
2017
Q4 | – | Sell |
-381
| Closed | -$70K | – | 554 |
|
|
2017
Q3 | $70K | Sell |
381
-197
| -34% | -$36.2K | 0.02% | 600 |
|
|
2017
Q2 | $109K | Sell |
578
-60
| -9% | -$11.3K | 0.03% | 516 |
|
|
2017
Q1 | $113K | Sell |
638
-206
| -24% | -$36.5K | 0.03% | 452 |
|
|
2016
Q4 | $121K | Buy |
844
+41
| +5% | +$5.88K | 0.02% | 622 |
|
|
2016
Q3 | $101K | Buy |
803
+272
| +51% | +$34.2K | 0.02% | 660 |
|
|
2016
Q2 | $69K | Buy |
531
+106
| +25% | +$13.8K | 0.02% | 567 |
|
|
2016
Q1 | $59K | Hold |
425
| – | – | 0.02% | 569 |
|
|
2015
Q4 | $59K | Sell |
425
-147
| -26% | -$20.4K | 0.02% | 575 |
|
|
2015
Q3 | $80K | Sell |
572
-253
| -31% | -$35.4K | 0.03% | 499 |
|
|
2015
Q2 | $135K | Hold |
825
| – | – | 0.05% | 397 |
|
|
2015
Q1 | $127K | Hold |
825
| – | – | 0.04% | 409 |
|
|
2014
Q4 | $104K | Sell |
825
-859
| -51% | -$108K | 0.03% | 440 |
|
|
2014
Q3 | $201K | Buy |
+1,684
| New | +$201K | 0.04% | 452 |
|